Company News

Nu Skin To Acquire Nox Technologies

Purchase expands company's anti-aging reach.

Author Image

By: TOM BRANNA

Editor

Nu Skin is looking for new avenues to find anti-aging solutions. The company will acquire Nox Technologies, Inc., a biotechnology and biodiagnostic company based in Malvern, PA for $12.5 million. The agreement includes the acquisition of technology and patents, including previously licensed technology already utilized in connection with Nu Skin’s anti-aging research efforts.


“The acquisition of Nox Technologies demonstrates our ongoing commitment to scientific innovation and provides us with additional tools to target the sources of aging,” said Chief Scientific Officer Joe Chang, Ph.D. “Furthermore, we believe the acquisition will enhance our long-term pipeline of scientifically validated anti-aging solutions for health, beauty and wellness.”

Nox Technologies provides Nu Skin scientists with a deeper understanding of the aging process and supports the company’s ability to understand important sources of aging. arNox, an age-related protein identified by Nox Technologies, is found on the cell surface and is capable of superoxide generation, a relevant aspect of the aging process.

According to Thomas B. Shelton, chief executive officer of Nox Technologies, “This merger is the culmination of many years of working with Nu Skin researchers on our arNox technology. Nox Technologies’ translation of the basic science around arNox paved the way for this unique technology to be incorporated into Nu Skin’s successful anti-aging research and development efforts.”

The acquisition is subject to customary closing conditions, including approval of the transaction by the stockholders of Nox Technologies, Inc.Closing is expected to occur prior to the end of 2012.

Keep Up With Our Content. Subscribe To Happi Newsletters